Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Spectral AI's share price for the quarter that ended in Mar. 2024 was $2.13. Spectral AI's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 17.48 Mil. Therefore, Spectral AI's market cap for the quarter that ended in Mar. 2024 was $37.24 Mil.
Spectral AI's quarterly market cap
declined
from Sep. 2023 ($40.26 Mil) to Dec. 2023 ($40.09 Mil) and
declined
from Dec. 2023 ($40.09 Mil) to Mar. 2024 ($37.24 Mil).
Spectral AI's annual market cap
stayed the same
from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then
increased
from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($40.09 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Spectral AI's Enterprise Value for Today is $23.35 Mil.
Spectral AI Market Cap Historical Data
The historical data trend for Spectral AI's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Spectral AI's Market Cap
For the Medical Devices subindustry, Spectral AI's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral AI's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's Market Cap distribution charts can be found below:
* The bar in red indicates where Spectral AI's Market Cap falls into.
Spectral AI Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Spectral AI's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral AI (NAS:MDAI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Spectral AI Market Cap Related Terms
Thank you for viewing the detailed overview of Spectral AI's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely and informed decision regarding the treatment of the patient's wound.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDAI has been successfully added to your